retatrutide fda approval status Status: July 2026 Update GLP-1 Medications for Weight Loss:

At the same time, GLP-1 receptor activation reduces the activity of pathogenic Th1 and Th17 cells, the effector T cells most directly responsible for autoimmune tissue damage

Know the risks, including those that aren't on the label Kessler worries about people taking the drugs going too far in the other direction from overeating to malnutrition

Most participants report minimal ongoing symptoms from month 4 forward

I was 57 at the time and had been on HRT for several years

Social eating dynamics often improve

Metabolism GLP-1 gets rapidly metabolized in the circulation by dipeptidyl peptidase-4 (DPP-IV), resulting in a short plasma half-life of approximately 2 min [11]